Health
NIH ‘very concerned’ about serious side effect in coronavirus vaccine trial – FiercePharma
While the FDA weighs whether to resume its trial of AstraZeneca’s COVID-19 vaccine, which triggered a clinical hold last week after a U.K. patient was hit with a serious side effect, the NIH has launched its own study into the reaction—which could take up to…
The Food and Drug Administration (FDA) is weighing whether to follow British regulators in resuming a coronavirus vaccine trial that was halted when a participant suffered spinal cord damage, even as the National Institutes of Health (NIH) has launched an investigation of the case.
The highest levels of NIH are very concerned, said Avindra Nath, M.D., intramural clinical director and a leader of viral research at the National Institute for Neurological Disorders and Stroke, an NIH division. Eve…
-
Business21 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
Noosa News20 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
General15 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Noosa News17 hours agoTips to improve engagement – Proctor